An ex vivo model employing keloid-derived cell-seeded collagen sponges for therapy development

Journal of Investigative Dermatology

Volumn 133, Issue 2, 2013, Pages 386-393

  Yagi, Yosuke ^a,b   Muroga, Eri ^a   Naitoh, Motoko ^a   Isogai, Zenzo ^c   Matsui, Seiya ^a,d   Ikehara, Susumu ^b   Suzuki, Shigehiko ^a   Miyachi, Yoshiki ^a   Utani, Atsushi ^b  

^a KYOTO UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^d Maruho Co   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN ABC LYASE; COLLAGEN SPONGE; GLYCOSAMINOGLYCAN; INTERLEUKIN 1BETA; PROTEOGLYCAN; VERSICAN;

ANIMAL EXPERIMENT; ARTICLE; FIBROBLAST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KELOID; MESENCHYME CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84872608877     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.314     Document Type: Article

References (23)

1. Al-Attar A, Mess S, Thomassen JM et al. (2006) Keloid pathogenesis and treatment. Plast Reconstr Surg 117:286-300
2. Butler PD, Longaker MT, Yang GP (2008) Current progress in keloid research and treatment. J Am Coll Surg 206:731-41
3. Chung HJ, Steplewski A, Chung KY et al. (2008) Collagen fibril formation. A new target to limit fibrosis. J Biol Chem 283:25879-86
4. Eto H, Suga H, Aoi N et al. (2012) Therapeutic potential of fibroblast growth factor-2 for hypertrophic scars: upregulation of MMP-1 and HGF expression. Lab Invest 92:214-23
5. Ikeda M, Naitoh M, Kubota H et al. (2009) Elastic fiber assembly is disrupted by excessive accumulation of chondroitin sulfate in the human dermal fibrotic disease, keloid. Biochem Biophys Res Commun 390:1221-8
6. Isogai Z, Shinomura T, Yamakawa N et al. (1996) 2B1 antigen characteristically expressed on extracellular matrices of human malignant tumors is a large chondroitin sulfate proteoglycan, PG-M/versican. Cancer Res 56:3902-8
7. Kahari VM, Larjava H, Uitto J (1991) Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture. J Biol Chem 266:10608-15
8. Kashiyama K, Mitsutake N, Matsuse M et al. (2012) miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblasts. J Invest Dermatol 132:1597-604
9. Koyama H, Hibi T, Isogai Z et al. (2007) Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Am J Pathol 170:1086-99
10. Lemire JM, Chan CK, Bressler S et al. (2007) Interleukin-1 beta selectively decreases the synthesis of versican by arterial smooth muscle cells. J Cell Biochem 101:753-66
11. Matsumoto K, Kamiya N, Suwan K et al. (2006) Identification and characterization of versican/PG-M aggregates in cartilage. J Biol Chem 281:18257-63
12. Mustoe TA, Cooter RD, Gold MH et al. (2002) International clinical recommendations on scar management. Plast Reconstr Surg 110: 560-71
13. Naitoh M, Kubota H, Ikeda M et al. (2005) Gene expression in human keloids is altered from dermal to chondrocytic and osteogenic lineage. Genes Cells 10:1081-91
14. Naso MF, Zimmermann DR, Iozzo RV (1994) Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter. J Biol Chem 269:32999-3008
15. Polo M, Kim YJ, Kucukcelebi A et al. (1998) An in vivo model of human proliferative scar. J Surg Res 74:187-95
16. Qwarnstrom EE, Jarvelainen HT, Kinsella MG et al. (1993) Interleukin-1 beta regulation of fibroblast proteoglycan synthesis involves a decrease in versican steady-state mRNA levels. Biochem J 294(Part 2):613-20
17. Ramos ML, Gragnani A, Ferreira LM (2008) Is there an ideal animal model to study hypertrophic scarring? J Burn Care Res 29:363-8
18. Smith JC, Boone BE, Opalenik SR et al. (2008) Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol 128:1298-310
19. Togo T, Utani A, Naitoh M et al. (2006) Identification of cartilage progenitor cells in the adult ear perichondrium: utilization for cartilage reconstruction. Lab Invest 86:445-57
20. van de Kar AL, Kreulen M, van Zuijlen PP et al. (2007) The results of surgical excision and adjuvant irradiation for therapy-resistant keloids: a prospective clinical outcome study. Plast Reconstr Surg 119:2248-54
21. Waki EY, Crumley RL, Jakowatz JG (1991) Effects of pharmacologic agents on human keloids implanted in athymic mice. A pilot study. Arch Otolaryngol Head Neck Surg 117:1177-81
22. Wolfram D, Tzankov A, Pulzl P et al. (2009) Hypertrophic scars and keloids-a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 35:171-81
23. Wu YJ, La Pierre DP, Wu J et al. (2005) The interaction of versican with its binding partners. Cell Res 15:483-94